Consumer Portfolio Services insider grant: 120,000 options, $8.19 exercise
Rhea-AI Filing Summary
Robert E. Riedl, Senior Executive Vice President of Consumer Portfolio Services (CPSS), was granted stock options. The award is for 120,000 stock options with an exercise price of $8.19. The options become exercisable in four equal increments beginning one year after grant and continuing annually through the fourth year, and they expire in 2032. The filing states the options were issued as consideration for services to the company and are held directly by the reporting person.
Positive
- Grant of 120,000 stock options to a senior executive is explicitly disclosed
- Exercise price stated at $8.19, providing clear terms of the option grant
- Vesting schedule specified: four equal increments beginning one year after grant through year four, and expiration in 2032
- Options issued as consideration for services, explicitly stated
Negative
- None.
Insights
TL;DR: Executive received a sizable option grant (120,000 options at $8.19), vesting over four years, expiring 2032.
This Form 4 documents a non-derivative issuance of stock options to the company’s Senior Executive Vice President. The grant size and multiyear vesting schedule are explicitly disclosed, as is the $8.19 exercise price and 2032 expiration. From a securities reporting perspective, the filing records compensation-related equity awarded for services and shows direct beneficial ownership of the options by the reporting person. No additional financial metrics, percentage ownership, or changes in existing holdings are provided in the filing.
TL;DR: Director/officer received service-based option award with standard multi-year vesting; disclosure is routine for insider compensation.
The document clearly states the award’s mechanics: 120,000 options, strike $8.19, vesting in four equal tranches starting one year after grant, with an expiration in 2032. The filing identifies the reporting person’s role as Senior Executive Vice President and indicates the options were issued as compensation for services. The disclosure is concise and limited to the transaction and vesting terms; it does not include grant valuation, shareholder approval references, or any changes to other holdings.